{"nct_id":"NCT03739138","title":"Intratumoral/Intralesional Administration of MK-4621/JetPEI™ With or Without Pembrolizumab in Participants With Advanced/Metastatic or Recurrent Solid Tumors (MK-4621-002)","status":"TERMINATED","status_verified_date":"2022-01","start_date":"2018-12-18","start_date_type":"ACTUAL","primary_completion_date":"2021-03-02","primary_completion_date_type":"ACTUAL","completion_date":"2021-03-02","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}